[Hub]/) : Traits : Impedance of whole body :

chr6:87,167,376-88,880,701

Best TWAS P=2.18e-10 · Best GWAS P=1.16e-10 conditioned to 0.00502

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 CommonMind Brain Pre-frontal Cortex ZNF292 0.04 0.05 lasso 12 0.03 4.1e-05 5.6 -5.8 8.6e-09 0.59 0.38 0.62 FALSE
2 GTEx Artery Aorta RP11-393I2.4 0.10 0.03 lasso 5 0.02 2.4e-02 4.7 -5.4 7.5e-08 0.62 0.13 0.77 FALSE
3 GTEx Cells EBV-transformed lymphocytes C6orf163 0.18 0.14 lasso 4 0.15 1.5e-05 5.5 5.4 7.1e-08 -0.58 0.50 0.28 FALSE
4 GTEx Cells Transformed fibroblasts SMIM8 0.18 0.14 lasso 5 0.12 1.4e-09 5.5 -5.4 5.6e-08 0.59 0.76 0.24 FALSE
5 GTEx Cells Transformed fibroblasts C6orf163 0.16 0.14 lasso 3 0.18 2.7e-13 5.4 5.6 2.7e-08 -0.55 0.84 0.16 FALSE
6 GTEx Nerve Tibial ZNF292 0.09 0.07 enet 16 0.10 1.5e-07 -5.9 -5.8 5.2e-09 0.71 0.39 0.61 FALSE
7 GTEx Nerve Tibial RP11-393I2.4 0.08 0.09 enet 18 0.09 6.8e-07 4.6 -5.7 1.6e-08 0.65 0.37 0.63 FALSE
8 GTEx Stomach C6orf163 0.10 0.06 lasso 1 0.05 2.3e-03 5.4 5.4 7.9e-08 -0.58 0.31 0.15 FALSE
9 METSIM Adipose C6orf164 0.05 0.06 lasso 8 0.06 9.3e-10 5.4 5.3 1.0e-07 -0.60 0.82 0.18 FALSE
10 ROSMAP Brain Pre-frontal Cortex SMIM8 0.21 0.33 enet 34 0.38 3.9e-52 -5.9 5.2 2.0e-07 -0.61 0.10 0.90 FALSE
11 ROSMAP Brain Pre-frontal Cortex SLC35A1 0.30 0.48 enet 25 0.50 5.7e-73 -6.2 -6.0 1.7e-09 0.95 0.03 0.97 FALSE
12 The Cancer Genome Atlas Breast Invasive Carcinoma C6orf164 0.06 0.05 blup 94 0.06 1.0e-11 -5.4 5.8 8.9e-09 -0.57 0.03 0.97 FALSE
13 The Cancer Genome Atlas Cervical Squamous Cell Carcinoma C6orf164 0.07 0.06 blup 95 0.05 2.0e-03 -6.1 6.1 1.4e-09 -0.72 0.02 0.96 FALSE
14 The Cancer Genome Atlas Colon Adenocarcinoma C6orf164 0.05 0.02 enet 8 0.02 1.9e-02 -5.9 5.8 8.2e-09 -0.67 0.02 0.74 FALSE
15 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma C6orf164 0.06 0.08 blup 94 0.08 8.3e-09 -5.9 6.1 1.0e-09 -0.69 0.01 0.99 FALSE
16 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma SLC35A1 0.02 0.01 blup 72 0.00 8.7e-02 -6.0 6.0 2.6e-09 -0.83 0.01 0.91 FALSE
17 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma C6orf164 0.11 0.12 blup 95 0.14 5.0e-15 -5.9 5.5 2.9e-08 -0.64 0.01 0.99 FALSE
18 The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma C6orf164 0.11 0.14 enet 8 0.12 1.6e-07 -5.9 6.1 9.2e-10 -0.68 0.01 0.99 FALSE
19 The Cancer Genome Atlas Brain Lower Grade Glioma C6orf164 0.04 0.02 blup 95 0.04 5.4e-05 5.4 6.3 2.2e-10 -0.70 0.03 0.97 TRUE
20 The Cancer Genome Atlas Lung Adenocarcinoma C6orf164 0.09 0.12 blup 95 0.11 4.1e-13 -5.9 5.8 8.0e-09 -0.71 0.01 0.99 FALSE
21 The Cancer Genome Atlas Lung Squamous Cell Carcinoma C6orf164 0.06 0.06 lasso 4 0.07 4.6e-08 -6.1 5.9 3.4e-09 -0.67 0.01 0.99 FALSE
22 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma C6orf163 0.06 0.02 blup 66 0.02 1.1e-02 5.4 5.9 4.0e-09 -0.65 0.06 0.66 FALSE
23 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma C6orf164 0.12 0.12 blup 95 0.14 7.4e-10 -5.5 5.9 3.2e-09 -0.72 0.02 0.98 FALSE
24 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma SLC35A1 0.04 0.03 lasso 5 0.02 1.3e-02 -6.2 6.2 7.6e-10 -0.94 0.01 0.90 FALSE
25 The Cancer Genome Atlas Pancreatic Adenocarcinoma C6orf164 0.07 0.11 enet 8 0.10 8.4e-05 -6.0 5.8 5.8e-09 -0.67 0.02 0.97 FALSE
26 The Cancer Genome Atlas Stomach Adenocarcinoma C6orf164 0.17 0.13 lasso 4 0.10 6.2e-08 -6.0 5.9 4.7e-09 -0.66 0.01 0.99 FALSE
27 The Cancer Genome Atlas Thyroid Carcinoma C6orf164 0.18 0.24 lasso 4 0.25 1.4e-24 -5.9 6.0 2.1e-09 -0.68 0.01 0.99 FALSE
28 The Cancer Genome Atlas Thyroid Carcinoma SLC35A1 0.08 0.07 enet 17 0.07 5.0e-07 -6.0 -5.9 4.2e-09 0.90 0.01 0.99 FALSE